PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation

Signalling pathways that mediate macrophage activation in disease are poorly understood. Here the authors show that inhibition of PARP9 and/or activation of PARP14 may attenuate macrophage-mediated vascular diseases, and also provide new insight into the development of effective therapies for other...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hiroshi Iwata, Claudia Goettsch, Amitabh Sharma, Piero Ricchiuto, Wilson Wen Bin Goh, Arda Halu, Iwao Yamada, Hideo Yoshida, Takuya Hara, Mei Wei, Noriyuki Inoue, Daiju Fukuda, Alexander Mojcher, Peter C. Mattson, Albert-László Barabási, Mark Boothby, Elena Aikawa, Sasha A. Singh, Masanori Aikawa
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2016
Materias:
Q
Acceso en línea:https://doaj.org/article/5d6435ff7410464bbef7e214ba9acd61
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5d6435ff7410464bbef7e214ba9acd61
record_format dspace
spelling oai:doaj.org-article:5d6435ff7410464bbef7e214ba9acd612021-12-02T17:31:50ZPARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation10.1038/ncomms128492041-1723https://doaj.org/article/5d6435ff7410464bbef7e214ba9acd612016-10-01T00:00:00Zhttps://doi.org/10.1038/ncomms12849https://doaj.org/toc/2041-1723Signalling pathways that mediate macrophage activation in disease are poorly understood. Here the authors show that inhibition of PARP9 and/or activation of PARP14 may attenuate macrophage-mediated vascular diseases, and also provide new insight into the development of effective therapies for other inflammatory disorders.Hiroshi IwataClaudia GoettschAmitabh SharmaPiero RicchiutoWilson Wen Bin GohArda HaluIwao YamadaHideo YoshidaTakuya HaraMei WeiNoriyuki InoueDaiju FukudaAlexander MojcherPeter C. MattsonAlbert-László BarabásiMark BoothbyElena AikawaSasha A. SinghMasanori AikawaNature PortfolioarticleScienceQENNature Communications, Vol 7, Iss 1, Pp 1-19 (2016)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Hiroshi Iwata
Claudia Goettsch
Amitabh Sharma
Piero Ricchiuto
Wilson Wen Bin Goh
Arda Halu
Iwao Yamada
Hideo Yoshida
Takuya Hara
Mei Wei
Noriyuki Inoue
Daiju Fukuda
Alexander Mojcher
Peter C. Mattson
Albert-László Barabási
Mark Boothby
Elena Aikawa
Sasha A. Singh
Masanori Aikawa
PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation
description Signalling pathways that mediate macrophage activation in disease are poorly understood. Here the authors show that inhibition of PARP9 and/or activation of PARP14 may attenuate macrophage-mediated vascular diseases, and also provide new insight into the development of effective therapies for other inflammatory disorders.
format article
author Hiroshi Iwata
Claudia Goettsch
Amitabh Sharma
Piero Ricchiuto
Wilson Wen Bin Goh
Arda Halu
Iwao Yamada
Hideo Yoshida
Takuya Hara
Mei Wei
Noriyuki Inoue
Daiju Fukuda
Alexander Mojcher
Peter C. Mattson
Albert-László Barabási
Mark Boothby
Elena Aikawa
Sasha A. Singh
Masanori Aikawa
author_facet Hiroshi Iwata
Claudia Goettsch
Amitabh Sharma
Piero Ricchiuto
Wilson Wen Bin Goh
Arda Halu
Iwao Yamada
Hideo Yoshida
Takuya Hara
Mei Wei
Noriyuki Inoue
Daiju Fukuda
Alexander Mojcher
Peter C. Mattson
Albert-László Barabási
Mark Boothby
Elena Aikawa
Sasha A. Singh
Masanori Aikawa
author_sort Hiroshi Iwata
title PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation
title_short PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation
title_full PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation
title_fullStr PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation
title_full_unstemmed PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation
title_sort parp9 and parp14 cross-regulate macrophage activation via stat1 adp-ribosylation
publisher Nature Portfolio
publishDate 2016
url https://doaj.org/article/5d6435ff7410464bbef7e214ba9acd61
work_keys_str_mv AT hiroshiiwata parp9andparp14crossregulatemacrophageactivationviastat1adpribosylation
AT claudiagoettsch parp9andparp14crossregulatemacrophageactivationviastat1adpribosylation
AT amitabhsharma parp9andparp14crossregulatemacrophageactivationviastat1adpribosylation
AT pieroricchiuto parp9andparp14crossregulatemacrophageactivationviastat1adpribosylation
AT wilsonwenbingoh parp9andparp14crossregulatemacrophageactivationviastat1adpribosylation
AT ardahalu parp9andparp14crossregulatemacrophageactivationviastat1adpribosylation
AT iwaoyamada parp9andparp14crossregulatemacrophageactivationviastat1adpribosylation
AT hideoyoshida parp9andparp14crossregulatemacrophageactivationviastat1adpribosylation
AT takuyahara parp9andparp14crossregulatemacrophageactivationviastat1adpribosylation
AT meiwei parp9andparp14crossregulatemacrophageactivationviastat1adpribosylation
AT noriyukiinoue parp9andparp14crossregulatemacrophageactivationviastat1adpribosylation
AT daijufukuda parp9andparp14crossregulatemacrophageactivationviastat1adpribosylation
AT alexandermojcher parp9andparp14crossregulatemacrophageactivationviastat1adpribosylation
AT petercmattson parp9andparp14crossregulatemacrophageactivationviastat1adpribosylation
AT albertlaszlobarabasi parp9andparp14crossregulatemacrophageactivationviastat1adpribosylation
AT markboothby parp9andparp14crossregulatemacrophageactivationviastat1adpribosylation
AT elenaaikawa parp9andparp14crossregulatemacrophageactivationviastat1adpribosylation
AT sashaasingh parp9andparp14crossregulatemacrophageactivationviastat1adpribosylation
AT masanoriaikawa parp9andparp14crossregulatemacrophageactivationviastat1adpribosylation
_version_ 1718380494712733696